Compound comparison

CJC-1295 (DAC) vs Ipamorelin · Component Comparison

Both peptides are present in our CJC/IPA reference blend, but they are mechanistically and structurally distinct. This comparison breaks down each component's specifications.

Shared characteristics

  • ·Both are GH-axis research reference compounds frequently co-studied
  • ·Both supplied lyophilized in our single-vial CJC/IPA blend at ≥99% individual purity
  • ·Both confirmed by ESI-MS for identity
  • ·Both ship under the same blend COA documenting individual purities

Side-by-side differences

AspectCJC / IPACJC / IPA
ClassGHRH analog (30-residue)GH secretagogue pentapeptide
Residue count30 + DAC moiety5 residues, C-terminal amide
Molecular weight3367.7 g/mol711.85 g/mol
Molecular formulaC152H252N44O42C38H49N9O5
CAS number863288-34-0170851-70-4
Distinguishing featureMaleimidopropionic acid (DAC) — albumin-conjugation moietyIncludes non-natural Aib and 2-naphthylalanine residues
Sensitive toHydrolysis above pH 7.5 (maleimide ring opens)Standard peptide degradation; relatively robust

When researchers choose each

CJC-1295 (DAC) is the longer, albumin-conjugating reference component for studies involving in-vitro half-life extension chemistry. Ipamorelin is the short pentapeptide reference for ligand-binding studies on GH secretagogue receptors. The blend pairs them for protocols requiring co-presence; individual single-component reference standards are available on request for institutional buyers.